Matthew Porteus
Program Director, Stanford Alpha Clinic · Stanford Health Care
Credentials: · · · ·
History
PresentStanford Alpha Clinic · Stanford Health Care
- Present
Institute of Stem Cell Biology and Regenerative Medicine Center · Stanford Health Care
- Present
MD · Stanford Health Care
- 2021–2024
Hematology and Medical Oncology
- 2018–2021
- 1994–1997
1993–1996
1986–1990
Research
Highly efficient endogenous human gene correction using designed zinc-finger nucleases
Nature · 2005 · 1,235 citations
Chemically modified guide RNAs enhance CRISPR-Cas genome editing in human primary cells
Nature Biotechnology · 2015 · Last of 15 authors · 885 citations
Activation of proto-oncogenes by disruption of chromosome neighborhoods
Science · 2016 · 801 citations
19 papers · 8 as a resident
15 papers · 1 as a resident
- JR
9 papers
8 papers
8 papers
8 papers · 1 as a resident
8 papers
7 papers
Grants
- 2026–2027
Center for Definitive and Curative Medicine Annual Symposium
National Center for Advancing Translational Sciences · R13
Contact PI · $30K · Stanford University
- 2018–2022
Homologous Recombination Mediated Gene Correction for the Hemoglobinopathies
National Heart, Lung, and Blood Institute · R01
Contact PI · $1.6M · Stanford University
- 2019–2020
National Heart, Lung, and Blood Institute · OT2
Contact PI · $1.2M · Stanford University
- 2015–2020
Genome Editing by Homologous Recombination to Create HIV Resistant Immune System
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $2M · Stanford University
Clinical trials
- 2021–2028
Study director · Recruiting · Phase 1, Phase 2
Kamau Therapeutics